Maternal floor infarction in autoimmune disease: Two cases

Pediatric Pathology and Laboratory Medicine

Volumn 16, Issue 2, 1996, Pages 293-298

  Bendon, Robert W ^a,b   Hommel, Amy B ^a,b  

^a KOSAIR CHILDREN'S HOSPITAL   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

autoimmune; maternal floor infarction; plasmin; systemic lupus erythematosus

Indexed keywords

ANTIBODY; ANTIGEN; CARDIOLIPIN ANTIBODY; CELL NUCLEUS ANTIGEN; DNA ANTIBODY; FIBRIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PARIETAL CELL ANTIBODY; PLASMIN; PREDNISONE; SMOOTH MUSCLE ANTIBODY; UROKINASE;

ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; CASE REPORT; DIAGNOSIS; HUMAN; PLACENTA DISORDER; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0029926582     PISSN: 10771042     EISSN: None     Source Type: Journal    
DOI: 10.1080/107710496175778     Document Type: Article

References (14)

1. Naeye RL. Maternal floor infarction. Hum Pathol 1985; 16:823-8.
2. Andres RL, Kuyper W, Resnik R, Piacquadio KM, Benirschke K. The association of maternal floor infarction of the placenta with adverse perinatal outcome. Am.J Obstet Gynecol 1990; 163:935-8.
3. Benirschke K, Kaufmann P. Pathology of the Human Placenta. 2nd ed. New York: Springer-Verlag, 1990;406-11.
4. Clewell WH, Manchester DK. Recurrent maternal floor infarction: A preventable cause of fetal death. AmJ Obstet Gynecol 1983;147:346-7.
5. Vernolf KK, Benirschke K. Kephart GM, Wasmoen TL, Gleich GJ. Maternal floor infarction: Relationship to X cells, major basic protein, and adverse perinatal outcome. Am J Obstet Gynecol 1992; 167:1355-63.
6. Gersell D. Chronic villitis, chronic chorioamnionitis, and maternal floor infarction. Semin Diagn Pathol 1993:10:2,51-66.
7. Ravne SC, Kraus FT. Placental thrombi and other vascular lesions. Classification, morphology and clinical correlations. Pathol Res Pract 1993:189:2-17.
8. Mandsager NT, Bendon R, Mostello D, Rosenn B, Miodovnik M, Siddiqi TA. Maternal floor infarction of the placenta: Prenatal diagnosis and clinical significance. Obstet Gynecol 1994:83:750-4.
9. I.indoff C, Astedt B. Plasminogen activator of urokinase type and its inhibitor of placenta! type in hypertensive pregnancies and in intrauterine growth retardation: Possible markers of placental function. AmJ Obstet Gynecol 1994:171:60-4.
10. ZiniJ-M, Murray S, Graham CH, et al. Characterization of urokinase receptor expression by human placental trophoblasts. Blood 1992:79:2917-29.
11. Multhaupt HAB, Mazar A, Cines DB, Warhol MJ, McCrae KR. Expression of urokinase receptors bv human trophoblast: A histochemical and ultrastructural analysis. Lab Invest 1994:71:392-400.
12. Out HJ, Derksen HWM, Christiaens GCML. Systemic lupus erythematosus and pregnancy. Obstet Gynecol Sun 1989:44:585-91.
13. Abramowsky CR, Vegas MA, Swinehart G, Gyves MT. Decidual vasculopathv of the placenta in lupus ervthematosus. N EnglJ Med 1980;303:668-72.
14. Labarrere CA, Catoggio IJ, Mullen EG, Althabe OH. Placental lesions in maternal autoimmune diseases. AmJ Reprod Immunol Microbiol 1986:12:78-86.